Gene · 4100
Papers1,534
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
41 to 60 of 1,534
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Development and validation of a TAAbs and TAAs based non-invasive model for diagnosing lung cancer. | Heliyon | 2024 | 39027487 | PubTator, text mining | PubMed |
| Pulsed electric field induces exocytosis and overexpression of MAGE antigens in melanoma. | Sci Rep | 2024 | 38822068 | PubTator, text mining | PubMed |
| The role of seven tumor-associated autoantibodies in the diagnosis, staging and treatment guidance of lung cancer. | BMC Pulm Med | 2024 | 38773432 | PubTator, text mining | PubMed |
| Clinical application of serum seven tumour-associated autoantibodies in patients with pulmonary nodules. | Heliyon | 2024 | 38765082 | PubTator, text mining | PubMed |
| Cross-reactive CD8+ T cell responses to tumor-associated antigens (TAAs) and homologous microbiota-derived antigens (MoAs). | J Exp Clin Cancer Res | 2024 | 38509571 | PubTator, text mining | PubMed |
| Designing, cloning and simulation studies of cancer/testis antigens based multi-epitope vaccine candidates against cutaneous melanoma: An immunoinformatics approach. | Biochem Biophys Rep | 2024 | 38371523 | PubTator, text mining | PubMed |
| Meta-analysis of microarray data to determine gene indicators involved in cisplatin resistance in non-small cell lung cancer. | Cancer Rep (Hoboken) | 2024 | 38351531 | PubTator, text mining | PubMed |
| Expression of MAGE A1 to MAGE A10 in the Forceps Biopsy and Bronchoalveolar Lavage Specimens from Patients with the Central Lung Tumor. | Asian Pac J Cancer Prev | 2024 | 38285780 | PubTator, text mining | PubMed |
| Differentiated genomic footprints suggest isolation and long-distance migration of Hmong-Mien populations. | BMC Biol | 2024 | 38273256 | PubTator, text mining | PubMed |
| Cancer Nano-Immunotherapy: The Novel and Promising Weapon to Fight Cancer. | Int J Mol Sci | 2024 | 38256268 | PubTator, text mining | PubMed |
| A Comprehensive Review of Immunotherapy Clinical Trials for Metastatic Urothelial Carcinoma: Immune Checkpoint Inhibitors Alone or in Combination, Novel Antibodies, Cellular Therapies, and Vaccines. | Cancers (Basel) | 2024 | 38254823 | PubTator, text mining | PubMed |
| Melanoma Antigen Family A (MAGE A) as Promising Biomarkers and Therapeutic Targets in Bladder Cancer. | Cancers (Basel) | 2024 | 38254738 | PubTator, text mining | PubMed |
| Grade 2, 3 and Dedifferentiated Chondrosarcomas: A Comparative Study of Isocitrate Dehydrogenase-Mutant and Wild-Type Tumors with Implications for Prognosis and Therapy. | Cancers (Basel) | 2024 | 38254737 | PubTator, text mining | PubMed |
| Neoantigen vaccine nanoformulations based on Chemically synthesized minimal mRNA (CmRNA): small molecules, big impact. | NPJ Vaccines | 2024 | 38238340 | PubTator, text mining | PubMed |
| Single-cell transcriptomic analysis of human pleura reveals stromal heterogeneity and informs in vitro models of mesothelioma. | Eur Respir J | 2024 | 38212075 | PubTator, text mining | PubMed |
| Integrated multi-omics analyses reveal the TM4SF family genes with prognostic and therapeutic relevance in hepatocellular carcinoma. | Aging (Albany NY) | 2024 | 38206300 | PubTator, text mining | PubMed |
| Glioblastoma vaccines: past, present, and opportunities. | EBioMedicine | 2024 | 38183840 | PubTator, text mining | PubMed |
| MAGE-A11 is a potential prognostic biomarker and immunotherapeutic target in gastric cancer. | Aging (Albany NY) | 2024 | 38180746 | PubTator, text mining | PubMed |
| A rare presentation of primary cardiac diffuse large B‑cell lymphoma: A case report. | Oncol Lett | 2024 | 38108070 | PubTator, text mining | PubMed |
| Diagnosis of Malignant Pulmonary Nodules Using a Combination of Tumor-associated Autoantibodies and Computed Tomography. | Am J Clin Oncol | 2024 | 38054473 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4100/papers?page=3